The evolving landscape of malaria necessitates a dynamic approach to therapy protocols. Current recommendations, often guided by the World Health Organization Authority, prioritize the use of artemisinin-based combination treatments (ACTs) as first-line therapy in most endemic regions. However, t

Generic drugs offer a cost-effective alternative to brand-name medications. They contain the same active ingredients as their brand-name counterparts and are held to the exact quality standards by regulatory agencies like the FDA. When a patent on a brand-name drug runs out, generic versions can